SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001144204-15-052850
Filing Date
2015-08-31
Accepted
2015-08-31 10:54:05
Documents
1
Group Members
AUGUSTINE LAWLORCHRISTOPHER MIRABELLI, PH.D.HAROLD R. WERNERHEALTHCARE PARTNERS VIII, L.P.HEALTHCARE PARTNERS VIII, LLCJAMES H. CAVANAUGH, PH.D.JOHN W. LITTLECHILD

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D v419166_sc13d.htm SC 13D 145567
  Complete submission text file 0001144204-15-052850.txt   147361
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 6507450655
CATALYST BIOSCIENCES, INC. (Subject) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-82442 | Film No.: 151083900
SIC: 2834 Pharmaceutical Preparations

Mailing Address 44 NASSAU STREET PRINCETON NJ 08542
Business Address 44 NASSAU STREET PRINCETON NJ 08542 609-430-3913
HealthCare Ventures VIII, L.P. (Filed by) CIK: 0001358990 (see all company filings)

IRS No.: 841684310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D